This page shows the latest Dihon news and features for those working in and with pharma, biotech and healthcare.
This area has been boosted over the past year with the acquisition of Merck &Co's consumer health division and the takeover of China-based Dihon Pharmaceutical.
The company reported revenues of 123m for 2013 with sales mainly coming in Dihon's home market of China. ... Dihon also has a reach in some emerging markets in Asia and Africa, including NIgera, Vietnam and Cambodia.
The company also bought Chinese based Dihon Pharmaceuticals, which specialises in OTC medicines and traditional herbal remedies, to increase its offering and presence in Asia.
Fresh from announcing a deal to buy Chinese over-the-counter drugmaker Dihon Pharmaceutical, Bayer also reported a 4 per cent sales decline for its consumer health division to 1.96bn - ... Consumer health should return to low- to mid-single-digit growth
Acquires Dihon Pharmaceutical as Algeta takeover closes. . Bayer has boosted its consumer healthcare operations in emerging markets with a deal to acquire China-based Dihon Pharmaceutical Group. ... According to its website, Dihon employs more than 2,
More from news
Approximately 1 fully matching, plus 4 partially matching documents found.
This was followed five months later by the smaller, but still notable, deal to acquire the Chinese consumer healthcare company Dihon Pharmaceutical for around $485m.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
At Swordfish Advertising, we believe building an effective brand shouldn't be stressful. Don't get us wrong; it takes blood, sweat...